NasdaqGM - Nasdaq Real Time Price • USD
Lantheus Holdings, Inc. (LNTH)
As of 9:41 AM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 10 | 9 |
| Avg. Estimate | 1.54 | 1.66 | 6.58 | 6.67 |
| Low Estimate | 1.52 | 1.59 | 6.5 | 3.26 |
| High Estimate | 1.62 | 1.74 | 6.65 | 7.96 |
| Year Ago EPS | 1.47 | 1.54 | 6.23 | 6.58 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 11 | 10 |
| Avg. Estimate | 348.45M | 356.1M | 1.43B | 1.54B |
| Low Estimate | 339.8M | 351.6M | 1.42B | 1.44B |
| High Estimate | 354.1M | 360.9M | 1.46B | 1.69B |
| Year Ago Sales | 300.78M | 305.75M | 1.3B | 1.43B |
| Sales Growth (year/est) | 15.80% | 16.50% | 10.60% | 7.10% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 1.26 | 1.31 | 1.32 | 1.45 |
| EPS Actual | 1.47 | 1.54 | 1.47 | 1.75 |
| Difference | 0.21 | 0.23 | 0.15 | 0.3 |
| Surprise % | 16.70% | 17.60% | 11.40% | 20.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.54 | 1.66 | 6.58 | 6.67 |
| 7 Days Ago | 1.55 | 1.66 | 6.58 | 6.67 |
| 30 Days Ago | 1.54 | 1.65 | 6.57 | 6.67 |
| 60 Days Ago | 1.52 | 1.58 | 6.29 | 6.38 |
| 90 Days Ago | 1.51 | 1.57 | 6.24 | 6.31 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 1 | -- |
| Up Last 30 Days | -- | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 2 | 1 | 1 | 1 |
Growth Estimates
| CURRENCY IN USD | LNTH | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 4.80% | -- | -- | 1.30% |
| Next Qtr. | 7.80% | -- | -- | 10.60% |
| Current Year | 5.60% | -- | -- | 5.10% |
| Next Year | 1.40% | -- | -- | 13.40% |
| Next 5 Years (per annum) | 37.73% | -- | -- | 11.21% |
| Past 5 Years (per annum) | 56.17% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | B. Riley Securities: Buy to Buy | 4/18/2024 |
| Reiterates | Truist Securities: Buy to Buy | 2/26/2024 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 2/23/2024 |
| Maintains | B. Riley Securities: Buy to Buy | 1/10/2024 |
| Initiated | TD Cowen: Outperform | 12/4/2023 |
| Initiated | Brookline Capital: Buy | 11/30/2023 |
Related Tickers
AMPH Amphastar Pharmaceuticals, Inc.
40.29
+0.30%
NBIX Neurocrine Biosciences, Inc.
140.49
+5.11%
SIGA SIGA Technologies, Inc.
8.49
+1.68%
ITCI Intra-Cellular Therapies, Inc.
75.20
+0.89%
ESPR Esperion Therapeutics, Inc.
2.0550
+7.59%
ZTS Zoetis Inc.
147.00
+1.00%
DVAX Dynavax Technologies Corporation
11.96
+0.97%
IRWD Ironwood Pharmaceuticals, Inc.
8.14
+0.99%
EOLS Evolus, Inc.
11.76
+0.34%
AQST Aquestive Therapeutics, Inc.
4.2900
-2.05%